Thursday, December 6, 2012 Wednesday, December 5, 2012- Unleashing Biotech Innovation With The Currency of Entrepreneurshipat Forbes (Wed, Dec 5)
- This Is the Future of Health Careat Motley Fool (Wed, Dec 5)
- Pfizer Experimental Drug Slows Late-Stage Breast Cancerat Bloomberg (Wed, Dec 5)
- Microsoft Demand Ramps Up and 3 Dow Movers Not to Missat Wall St. Cheat Sheet (Wed, Dec 5)
- Why the Dow's Roaring Past 13,000at Motley Fool (Wed, Dec 5)
- Dow Today: Pfizer (PFE) Higherat TheStreet (Wed, Dec 5)
- The Worst of 2012: Horizon Pharmaceuticalsat Motley Fool (Wed, Dec 5)
- The Worst of 2012: Trius Therapeuticsat Motley Fool (Wed, Dec 5)
- Lundbeck to Begin Late-Stage Trials on Alzheimer’s Drug Mid-2013at Bloomberg (Wed, Dec 5)
- New Drug Approval Rate At Near-Record High, FDA Saysat Forbes (Wed, Dec 5)
- Pfizer says drug slows breast cancer progressionAP (Wed, Dec 5)
- Reports: Pfizer Laying Off U.S. Sales Staffat Motley Fool (Wed, Dec 5)
- Roche, Pfizer, Sanofi Plan $72.7 Million Stem-Cell Bankat Bloomberg (Wed, Dec 5)
- Tanzania expands immunization program to include Pfizer's Prevenar 13theflyonthewall.com (Wed, Dec 5)
- Tanzania Expands Immunization Program To Include Pfizer’s Prevenar 13 For Prevention Of Pneumococcal DiseaseBusiness Wire (Wed, Dec 5)
- Why SciClone Lost in Novemberat Motley Fool (Wed, Dec 5)
- Lpath Granted Key European Patent Related to iSONEP Drug ProgramMarketwired (Wed, Dec 5)
- Pfizer Presents Phase 2 Data Showing Investigational Therapy PD-0332991 Plus Letrozole Significantly Improved Progression Free Survival Compared With Letrozole Alone In Patients With ER Positive, HER2 Negative Advanced Breast CancerBusiness Wire (Wed, Dec 5)
- Number of Companies Paying Special Dividend Rising Rapidly in 2012 as Dividend Tax Increase LoomsMarketwired (Wed, Dec 5)
Tuesday, December 4, 2012Add PFE News to My Yahoo!   | |
|
0.57(2.00%) 3:05PM EDT - Nasdaq Real Time Price